Demand for Radiotherapy Projected to Rise in Asia-Pacific

1
Hospitals Deploying Radiotherapy Equipment to
Treat Cancer
2
According to the Global Cancer Observatory
(GLOBOCAN), 2020 saw a total of 19.3 million
cancer cases and 10 million cancer deaths
worldwide. The International Agency for Research
on Cancer (IARC) states that globally, 1 in 5
people are affected by cancer during their
lifetime, and 1 in 11 women and 1 in 8 men die of
it. As per research, socio-economic factors and
aging are the prime causes of cancer. Owing to
this reason, the usage of radiotherapy is
expected to increase in the coming
years. Additionally, technological advancements
in radiation therapy are projected to accelerate
the radiotherapy market at a CAGR of 8.4 during
the forecast period (20202030). For instance,
automated products are being incorporated into
clinical practice systems to enhance the
treatment process. Moreover, the advent of
more-precise forms of radiotherapy treatment,
such as volumetric modulated arc therapy (VMAT),
proton therapy, stereotactic radiosurgery (SRS),
brachytherapy, and image-guided radiation therapy
(IGRT), will help the market revenue increase
from 7,222.4 million in 2019 to 17,194.4
million by 2030. Receive Sample Copy of this
Report https//www.psmarketresearch.com/market-an
alysis/radiotherapy-market-revenue/report-sample
3
The type segment of the radiotherapy market is
categorized into external beam, internal beam,
and systemic. Amongst these, the external beam
category is expected to generate the highest
revenue over the forecast period. It can be
attributed to the rising prevalence of cancer and
escalating research activities across the world.
External-beam is the most commonly used types of
radiation therapy, wherein tumors can be
destroyed by projecting radiation from a machine
outside the body. Radiotherapy is primarily used
in hospitals as they are the initial point of
contact for the diagnosis and treatment of
diseases. These healthcare facilities offer the
best-possible services due to the presence of
trained healthcare professionals and
technologically advanced medical devices.
Moreover, the increasing cases of cancer, booming
geriatric population, and growing healthcare
expenditure will lead to the largescale adoption
of radiotherapy devices in hospitals. In addition
to hospitals, cancer research institutes and
independent radiotherapy centers deploy
radiotherapy devices to develop new technologies
and diagnose tumors, respectively. Make an
Enquiry before Purchase https//www.psmarketresea
rch.com/send-enquiry?enquiry-urlradiotherapy-mark
et-revenue
4
According to PS Intelligence, North America
registered the highest installation rate of
radiotherapy devices in 2019, due to the strong
presence of private healthcare providers and
research institutes, which are deploying
radiotherapy equipment in large numbers. Of the
North American countries, the U.S. adopted the
higher number of radiotherapy devices due to the
existence of improved healthcare settings, heavy
investments by the government, and high
prevalence of cancer. The U.S., along with
Canada, is expected to deploy radiotherapy
equipment on a substantial scale in the coming
years, due to an exponential rise in the number
of patients.
5
Disclaimer PS Intelligence always keeps its
customers interests at the core while carrying
out research activities. PS Intelligence ensures
the reliability and accuracy of information and
data provided in its market research
publications. However, the information in
publications is subject to fluctuations, as it is
based on primary interviews of officials from
various companies or organizations. PS
Intelligence is not responsible for any incorrect
data provided by the key industry players of the
concerned domain. the information or analysis in
PS Intelligence publications represents opinions
based on research and should not be interpreted
as statements of fact. Information in this report
was believed to be correct at the time of
publication, but cannot be guaranteed. PS
Intelligence does not endorse any product,
service, or vendor depicted in its research
publications. All intellectual properties,
including trademarks and copyrights, belong to
their respective owners and may be protected by
copyright. Under no circumstance can these be
reproduced in any form without prior written
agreement of their owners. An order for market
research report is intended for internal use of
the company only and not for disclosure to third
parties or any other publication in general. No
service, report, or part thereof provided by PS
Intelligence can be reproduced, republished,
resold, revealed, distributed, circulated, or
sublicensed in any medium or form now realized or
hereafter become realized, including but not
limited to, all forms of optical-based media,
magnetic, electronic, or digital, without a
written permission from Prescient Strategic
Intelligence Pvt. Ltd.